Trials / Completed
CompletedNCT02305277
Relative Bioavailability and Bioequivalence Of Different Formulations of Opicapone in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 85 (actual)
- Sponsor
- Bial - Portela C S.A. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Single-centre, open-label, randomised, three-part, two-way crossover study in 84 healthy volunteers. In each part, the study consisted of two consecutive single-dose treatment periods separated by a washout period of at least 14 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BIA 9-1067 (clinical micronized, CM) | |
| DRUG | BIA 9-1067 (to-be-marketed, TBM) |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2014-12-02
- Last updated
- 2025-03-12
- Results posted
- 2015-11-17
Source: ClinicalTrials.gov record NCT02305277. Inclusion in this directory is not an endorsement.